Biopharma firm to commence phase 2 study of oral small molecule drug for Parkinson's

Retrieved on: 2024-02-23 16:19:46

Tags for this article:

Click the tags to see associated articles and topics

Biopharma firm to commence phase 2 study of oral small molecule drug for Parkinson's. View article details on hiswai:

Summary

The key concept of neuroscience is exemplified in an article about a biopharma firm commencing a phase 2 study of dapansutrile for Parkinson's. The tags "Email" and "Dapansutrile" highlight the article's relevance to communication updates about the drug trial.

Article found on: www.healio.com

View Original Article